Competitive Technologies to Submit Compliance Plan to NYSE Alternext

Plan Follows Receipt of Non-Compliance Letter From NYSE Alternext


FAIRFIELD, Conn., Dec. 4, 2008 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Alternext US:CTT) announced today that it has been notified by the NYSE Alternext US that CTT is in financial non-compliance with continued listing standards of the exchange. Under the standards, CTT has 30 days to respond with a business plan that demonstrates its ability to achieve, within 18 months, compliance with the listing standards. CTT will submit such a plan. In the meantime, the stock continues to trade at NYSE Alternext US.

CTT was notified on December 2, 2008 that it had fallen below the Section 1003(a)(ii) standard of the NYSE Alternext US Company Guide by having shareholders' equity of less than $4 million and losses from continuing operations and/or net losses in three out of its four most recent fiscal years as reported and fully disclosed in the most recent Form 10-K filed October 28, 2008.

"In the business plan we submit, we will emphasize the progress in the marketing of our pain management medical device, including the four signed country-exclusive distribution agreements for India, Korea, Bangladesh and Malaysia, the CE Mark approval for sale of the device in Europe, and our pending FDA 510(k) application for sale of the device in the United States," said John B. Nano, CTT's Chairman President, and CEO. "We will also describe the equity financing arrangement we signed in July 2008 with Fusion Capital for up to $5.0 million of cash through sale of our common stock, at our option. Of the $5.0 million, $4.9 million remained available at October 31, 2008."

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, provides distribution, patent and technology transfer, sales and licensing services focused on the needs of its customers and matching those requirements with commercially viable product or technology solutions. CTT is a global leader in identifying, developing and commercializing innovative products and technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: www.competitivetech.net

Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2008, filed with the SEC on October 28, 2008, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.



            

Contact Data